Levamisole (Ergamisol)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 13:58, 17 September 2020 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

This agent is not commercially available in the United States and is included for historic purposes only.

Diseases for which it was used

History of changes in FDA indication

6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.

Also known as

Brand name: Ergamisol

Retrieved from "https://hemonc.org/w/index.php?title=Levamisole_(Ergamisol)&oldid=45647"